Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

VKTX

Viking Therapeutics Inc

Feb 14 • 04:00PM ET

30.48

Dollar change +0.98
Percentage change 3.32	%

Healthcare • Biotechnology • USA • NASD

Peers: MDGL AKRO GLMD AKBA PRTG ARDX BOLD CARA EYPT FGEN

| Held by: VTI VB XBI VXF VBK IWP SCHA VHT IWF IWR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.01	Insider Own	3.14%	Shs Outstand	111.57M	Perf Week	-6.39%
Market Cap	3.40B	Forward P/E	-	EPS next Y	-2.16	Insider Trans	-19.02%	Shs Float	107.93M	Perf Month	-12.56%
Income	-109.96M	PEG	-	EPS next Q	-0.33	Inst Own	74.48%	Short Float	22.17%	Perf Quarter	-49.70%
Sales	0.00M	P/S	-	EPS this Y	-57.98%	Inst Trans	-0.45%	Short Ratio	6.17	Perf Half Y	-47.63%
Book/sh	7.89	P/B	3.86	EPS next Y	-35.26%	ROA	-17.22%	Short Interest	23.93M	Perf Year	-0.39%
Cash/sh	8.10	P/C	3.76	EPS next 5Y	-	ROE	-17.90%	52W Range	28.64 - 99.41	Perf YTD	-24.25%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-23.00%	ROI	-12.48%	52W High	-69.34%	Beta	0.87
Dividend TTM	-	Quick Ratio	36.47	Sales past 5Y	0.00%	Gross Margin	-	52W Low	6.42%	ATR (14)	2.08
Dividend Ex-Date	-	Current Ratio	33.09	EPS Y/Y TTM	-10.27%	Oper. Margin	-	RSI (14)	36.55	Volatility	5.27% 6.36%
Employees	27	Debt/Eq	0.00	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.12	Target Price	99.29
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	-29.41%	Payout	-	Rel Volume	0.82	Prev Close	29.50
Sales Surprise	-	EPS Surprise	-15.98%	Sales Q/Q	-	Earnings	Feb 05 AMC	Avg Volume	3.88M	Price	30.48
SMA20	-5.85%	SMA50	-21.64%	SMA200	-44.99%	Trades		Volume	3,184,229	Change	3.32%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-13-25	Initiated	Scotiabank	Sector Outperform	$102
Feb-07-25	Initiated	Citigroup	Neutral	$38
Dec-02-24	Initiated	Piper Sandler	Overweight
Nov-22-24	Initiated	B. Riley Securities	Buy	$109
Nov-04-24	Reiterated	H.C. Wainwright	Buy	$90 → $102
Sep-11-24	Initiated	JP Morgan	Overweight	$80
Jun-27-24	Initiated	Morgan Stanley	Overweight	$105
May-16-24	Upgrade	Raymond James	Outperform → Strong Buy	$115 → $116
Mar-26-24	Reiterated	Oppenheimer	Outperform	$116 → $138
Mar-07-24	Initiated	Jefferies	Buy	$110
Feb-28-24	Reiterated	Oppenheimer	Outperform	$46 → $116
May-31-23	Resumed	ROTH MKM	Buy	$32
Mar-28-23	Reiterated	Maxim Group	Buy	$15 → $25
Mar-17-23	Initiated	Stifel	Buy	$22
Jul-29-21	Resumed	BTIG Research	Buy	$20
May-25-21	Downgrade	Raymond James	Strong Buy → Outperform	$27 → $12
Jun-05-20	Initiated	BMO Capital Markets	Outperform	$14
May-05-20	Initiated	Chardan Capital Markets	Buy	$15
May-01-20	Initiated	BTIG Research	Buy	$9
Jul-16-19	Initiated	Oppenheimer	Outperform	$12

Show Previous Ratings

Feb-11-25 09:33AM	Why Viking Therapeutics Inc. (VKTX) Went Down on Monday (Insider Monkey)
Feb-10-25 07:13PM	Why Hims & Hers Health Stock Crushed Novo Nordisk and Viking Therapeutics Today (Motley Fool) -7.34%
09:00AM	2 Stocks to Buy With Less Than $40 (Motley Fool)
04:20AM	3 No-Brainer Healthcare Stocks to Buy With $200 Right Now (Motley Fool)
Feb-08-25 04:27PM	The M&A boom of 2025 is just getting started and here are 5 potential targets (MarketWatch)
09:10AM	Loading…
09:10AM	Viking Therapeutics price target lowered to $96 from $109 at B. Riley (TipRanks)
08:50AM	2 Stocks That Could Soar Again in 2025 (Motley Fool)
03:57AM	Down 65%, Is Viking Therapeutics Stock a Buy on the Dip? (Motley Fool)
Feb-07-25 05:30AM	The Drug Industry Is Having Its Own DeepSeek Moment (The Wall Street Journal)
Feb-06-25 04:02PM	Viking Therapeutics Plunged 6% On Its Earnings Report. Here's Why. (Investor's Business Daily) -6.09%
12:15PM	Viking Therapeutics Plummeted 7% On Its Earnings Report. Here's Why. (Investor's Business Daily)
11:51AM	Viking Therapeutics Reports Q4 2024 Financial Results, Advances VK2735 Trials (GuruFocus.com)
08:15AM	Has the Bubble Burst for Viking Therapeutics Stock? (Motley Fool)
07:40AM	Q4 2024 Viking Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
02:14AM	Viking Therapeutics Inc (VKTX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Rising ... (GuruFocus.com)
04:55PM	Loading…
Feb-05-25 04:55PM	Viking Therapeutics, Inc. (VKTX): One of Januarys Biggest Losers (Insider Monkey)
04:05PM	Viking Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update (PR Newswire)
09:30AM	Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It? (Zacks)
Feb-04-25 02:40AM	Why Does Jim Cramer Prefer Eli Lilly (LLY) Over Viking Therapeutics? (Insider Monkey)
Feb-02-25 07:44AM	Jim Cramer's Take on Viking Therapeutics (VKTX): 'Sell Viking Therapeutics and Roll it into Viking Holdings' (Insider Monkey)
06:36AM	This Weight Loss Stock Could Soar Over 220%, According to Wall Street. Time to Buy? (Motley Fool)
Jan-31-25 08:29AM	Jim Cramer Says I Want You To Sell Viking Therapeutics, Inc. (VKTX) And Roll It Into Viking Holdings (Insider Monkey)
Jan-30-25 05:45PM	Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know (Zacks)
Jan-29-25 04:05PM	Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2024 on February 5, 2025 (PR Newswire)
Jan-24-25 04:17PM	Novo Nordisk Surges As Next-Gen Obesity Drug Outperforms (Investor's Business Daily)
08:38AM	Novo Nordisk Jumps On Experimental Weight-Loss Drug Trial Results (Investor's Business Daily)
Jan-23-25 07:38AM	This Weight-Loss Drug Stock Could Gain 200%. The Case for It to Challenge Novo, Lilly. (Barrons.com)
Jan-22-25 04:10AM	This Biotech Stock Soared 116% in 2024, but Is It a Buy in 2025? (Motley Fool)
Jan-21-25 05:50PM	Viking Therapeutics, Inc. (VKTX) Increases Yet Falls Behind Market: What Investors Need to Know (Zacks)
05:00AM	The race for the next Ozempic is on (Quartz)
09:30AM	Loading…
Jan-20-25 09:30AM	Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views? (Zacks)
01:05AM	Why Viking Therapeutics, Inc. (VKTX) Crashed Last Week (Insider Monkey)
Jan-17-25 11:37AM	Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today (Motley Fool)
11:00AM	Why Viking Therapeutics (VKTX) Is the Biotech Stock with Biggest Upside Potential (Insider Monkey)
Jan-15-25 09:00PM	Lightning Round: Sell Viking Therapeutics, says Jim Cramer (CNBC TV) -6.60%
Jan-14-25 01:04PM	JPM25: Amgens defense, Mercks patent hill and Vikings long-term planning (BioPharma Dive) -12.73%
12:11PM	Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday (Motley Fool)
Jan-13-25 05:50PM	Viking Therapeutics, Inc. (VKTX) Stock Sinks As Market Gains: What You Should Know (Zacks)
10:57AM	Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts. (Investor's Business Daily)
Jan-09-25 07:26AM	Viking Therapeutics begins VK2735 Phase II trial for obesity treatment (Clinical Trials Arena)
04:20AM	3 Mid-Cap Stocks That Could Take Off in 2025 (Motley Fool)
Jan-08-25 07:03AM	Viking Therapeutics Announces Initiation of Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity (PR Newswire)
Jan-06-25 05:50PM	Viking Therapeutics, Inc. (VKTX) Stock Sinks As Market Gains: What You Should Know (Zacks)
04:05PM	Viking Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Jan-04-25 04:23PM	Why Viking Therapeutics Stock Plummeted by 24% in December (Motley Fool)
Jan-03-25 09:30AM	Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic? (Zacks)
08:20AM	From Davids to Goliaths: the GLP-1RA gold rush (Pharmaceutical Technology)
08:00AM	Should You Buy the Dip on This High-Flying Stock? (Motley Fool)
Jan-01-25 01:27PM	Why Is Viking Therapeutics, Inc. (VKTX) Among the Best Multibagger Stocks to Buy Right Now? (Insider Monkey)
Dec-31-24 05:45PM	Viking Therapeutics, Inc. (VKTX) Advances While Market Declines: Some Information for Investors (Zacks)
Dec-29-24 06:47AM	3 Stocks That Could Be Monster Winners in 2025 (Motley Fool)
Dec-26-24 05:50PM	Viking Therapeutics, Inc. (VKTX) Gains As Market Dips: What You Should Know (Zacks)
Dec-24-24 11:31PM	Will Viking Therapeutics, Inc. (VKTX) Make You Rich In 2025? (Insider Monkey)
12:20PM	3 biggest catalysts expected for healthcare in 2025 (Yahoo Finance Video)
Dec-23-24 10:30AM	Is Viking Therapeutics, Inc. (VKTX) the Best Performing Biotech Stock in 2024? (Insider Monkey)
07:22AM	Hot Obesity Drug Market Will Keep Investors Gripped Next Year (Bloomberg)
Dec-21-24 06:26AM	Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck? (Motley Fool)
04:05AM	My Top 10 Stocks to Buy for 2025 (Motley Fool)
Dec-20-24 06:32PM	Why Viking Therapeutics Tumbled by More Than 10% This Week (Motley Fool)
05:45PM	Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know (Zacks)
04:11PM	Novo Crashes After Obesity Drug Misses Lofty Expectations. Lilly, Viking And Amgen Surge. (Investor's Business Daily)
12:20PM	Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up (Motley Fool)
11:52AM	Novo Crashes 19% After New Obesity Drug Misses Forecasts. Lilly, Viking, Amgen Jump. (Investor's Business Daily)
10:31AM	Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf? (Investor's Business Daily)
08:17AM	Novo Nordisk Dives On CagriSegma Obesity Drug Trial. Eli Lilly, Viking Jump. (Investor's Business Daily)
Dec-18-24 04:06PM	Viking Plummets After Merck Inks A $2.01 Billion Obesity Deal With Someone Else (Investor's Business Daily) -18.03% +8.39%
01:54PM	Why Viking Therapeutics (VKTX), HEICO Corporation (HEI), and ABM Industries (ABM) Stocks Are Plunging Today? (Insider Monkey)
01:12PM	What's Going On With Viking Therapeutics Stock On Wednesday? (Benzinga)
10:25AM	Merck Licenses a Weight-Loss Pill. Its Bad News for Obesity Biotechs. (Barrons.com)
Dec-17-24 05:47AM	Is Viking Therapeutics, Inc. (VKTX) the Best Weight Loss Stock to Buy Now According to Hedge Funds? (Insider Monkey)
Dec-16-24 04:15AM	Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030 (Motley Fool)
Dec-15-24 07:37AM	2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street (Motley Fool)
Dec-13-24 05:45PM	Viking Therapeutics, Inc. (VKTX) Stock Moves -1.75%: What You Should Know (Zacks)
Dec-10-24 04:10AM	Warning: This Skyrocketing Stock Has a Hidden Risk (Motley Fool)
Dec-05-24 07:15AM	Should You Forget Pfizer and Buy These Unstoppable Stocks Instead? (Motley Fool)
Dec-03-24 08:27AM	After Crashing 27% in the Past Month, Is Viking Therapeutics Stock a Bargain Buy Right Now? (Motley Fool)
07:00AM	2 Disruptive Growth Stocks With Room to Run (Motley Fool)
Nov-28-24 01:17PM	Here's Yet Another Reason to Buy Viking Therapeutics Stock Like There's No Tomorrow (Motley Fool)
Nov-26-24 05:16PM	Amgen Dives 5% Despite 'Truly Remarkable' Results For Obesity Treatment (Investor's Business Daily)
01:04PM	Amgen Crashes 9% Despite 'Truly Remarkable' Results For Obesity Treatment (Investor's Business Daily)
Nov-25-24 04:21AM	Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst (Motley Fool)
Nov-23-24 06:30AM	3 Monster Stocks in the Making (Motley Fool)
Nov-22-24 04:17PM	RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried? (Investor's Business Daily)
11:31AM	Why Is Viking Therapeutics (VKTX) Down 29.5% Since Last Earnings Report? (Zacks)
08:00AM	Weight-Loss Drugs Don't Seem To Impress RFK Jr. Should Eli Lilly, Novo Nordisk Investors Worry? (Investor's Business Daily)
Nov-21-24 04:46PM	Do Redditors Think That Viking Therapeutics Inc. (VKTX) Has a Big Upside Potential? (Insider Monkey)
Nov-20-24 01:26PM	Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs (Benzinga)
Nov-19-24 04:03PM	Viking Therapeutics Presents Results from Phase 2b VOYAGE Study of VK2809 in Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting 2024 (PR Newswire)
Nov-18-24 04:45AM	3 Things You Need to Know if You Buy Viking Therapeutics Today (Motley Fool)
Nov-17-24 07:05AM	Is It Too Late to Buy Viking Therapeutics Stock? (Motley Fool)
Nov-16-24 05:30AM	Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On. (Motley Fool)
Nov-15-24 04:05AM	Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead? (Motley Fool) -7.45%
Nov-13-24 04:06PM	Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand? (Investor's Business Daily) -9.14%
09:45AM	Did Viking Therapeutics Just Say "Checkmate" To Eli Lilly? (Motley Fool)
Nov-12-24 04:05PM	Viking Therapeutics to Present Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting 2024 (PR Newswire)
Nov-10-24 05:15AM	Is Viking Therapeutics a Buy on the Dip? (Motley Fool)
Nov-08-24 07:10AM	4 Reasons Why Buying Viking Therapeutics Stock Right Now Is a Smart Move (Motley Fool)
Nov-07-24 10:15AM	Got $5,000? Viking Therapeutics Stock Just Got a Big New Green Flag (Motley Fool)
07:00AM	Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance (Business Wire)
Nov-05-24 01:02PM	Viking Therapeutics Offers An Obesity Drug for Healthy Adults (GuruFocus.com)

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lian Brian	President & CEO	Jan 06 '25	Sale	42.75	194,490	8,313,601	2,366,570	Jan 06 08:16 PM
Mancini Marianna	Chief Operating Officer	Jan 06 '25	Sale	42.75	54,215	2,317,599	374,134	Jan 06 08:15 PM
ZANTE GREG	Chief Financial Officer	Jan 06 '25	Sale	42.75	50,309	2,150,595	165,259	Jan 06 08:14 PM
GREG ZANTE	Officer	Jan 06 '25	Proposed Sale	42.75	50,309	2,150,594		Jan 06 05:32 PM
MARIANNA MANCINI	Officer	Jan 06 '25	Proposed Sale	42.75	54,215	2,317,599		Jan 06 05:25 PM
BRIAN LIAN	Officer	Jan 06 '25	Proposed Sale	42.75	194,490	8,313,611		Jan 06 05:16 PM
MACARTNEY LAWSON	Director	Nov 08 '24	Option Exercise	5.80	2,000	11,600	49,965	Nov 08 06:22 PM
MACARTNEY LAWSON	Director	Nov 08 '24	Sale	68.67	2,000	137,333	47,965	Nov 08 06:22 PM
LAWSON MACARTNEY	Director	Nov 08 '24	Proposed Sale	68.67	2,000	137,333		Nov 08 06:13 PM
ZANTE GREG	Chief Financial Officer	Oct 28 '24	Option Exercise	7.49	94,001	704,282	281,053	Oct 28 09:48 PM
ZANTE GREG	Chief Financial Officer	Oct 28 '24	Sale	76.61	131,687	10,089,164	149,366	Oct 28 09:48 PM
GREG ZANTE	Officer	Oct 28 '24	Proposed Sale	78.03	131,687	10,275,537		Oct 28 04:37 PM
Rouan Sarah Kathryn	Director	Oct 25 '24	Option Exercise	4.88	11,000	53,680	11,000	Oct 25 07:28 PM
Rouan Sarah Kathryn	Director	Oct 25 '24	Sale	80.89	11,000	889,790	0	Oct 25 07:28 PM
SINGLETON J MATTHEW	Director	Oct 25 '24	Option Exercise	4.48	16,000	71,680	25,500	Oct 25 07:27 PM
SINGLETON J MATTHEW	Director	Oct 25 '24	Sale	79.50	16,000	1,272,000	9,500	Oct 25 07:27 PM
Rouan Sarah Kathryn	Director	Oct 25 '24	Proposed Sale	80.86	11,000	889,430		Oct 25 04:10 PM
SINGLETON J MATTHEW	Director	Oct 25 '24	Proposed Sale	79.47	16,000	1,271,479		Oct 25 04:01 PM
SINGLETON J MATTHEW	Director	Sep 20 '24	Option Exercise	1.19	10,300	12,257	19,800	Sep 20 09:21 PM
SINGLETON J MATTHEW	Director	Sep 20 '24	Sale	69.50	10,300	715,850	9,500	Sep 20 09:21 PM
Lian Brian	President & CEO	Sep 20 '24	Option Exercise	7.77	166,130	1,290,830	2,521,057	Sep 20 09:20 PM
Lian Brian	President & CEO	Sep 20 '24	Sale	70.83	216,130	15,308,553	2,304,927	Sep 20 09:20 PM
Lian Brian	Officer	Sep 20 '24	Proposed Sale	18.41	216,130	3,978,372		Sep 20 04:29 PM
SINGLETON J MATTHEW	Director	Sep 20 '24	Proposed Sale	69.50	10,300	715,850		Sep 20 04:13 PM
Lian Brian	President & CEO	Aug 21 '24	Option Exercise	7.77	1,000	7,770	2,355,927	Aug 22 07:23 PM
Lian Brian	President & CEO	Aug 21 '24	Sale	69.90	1,000	69,900	2,354,927	Aug 22 07:23 PM
SINGLETON J MATTHEW	Director	Aug 21 '24	Option Exercise	1.19	5,700	6,783	15,200	Aug 22 07:23 PM
SINGLETON J MATTHEW	Director	Aug 21 '24	Sale	69.72	5,700	397,430	9,500	Aug 22 07:23 PM
Lian Brian	Officer	Aug 21 '24	Proposed Sale	69.90	1,000	69,900		Aug 21 04:30 PM
SINGLETON J MATTHEW	Director	Aug 21 '24	Proposed Sale	69.72	5,700	397,404		Aug 21 04:18 PM
Lian Brian	President & CEO	Aug 19 '24	Option Exercise	7.77	112,870	877,000	2,467,797	Aug 19 08:13 PM
Lian Brian	President & CEO	Aug 19 '24	Sale	65.80	112,870	7,426,508	2,354,927	Aug 19 08:13 PM
SINGLETON J MATTHEW	Director	Aug 19 '24	Option Exercise	3.33	16,000	53,280	25,500	Aug 19 08:11 PM
SINGLETON J MATTHEW	Director	Aug 19 '24	Sale	62.22	16,000	995,453	9,500	Aug 19 08:11 PM
Lian Brian	Officer	Aug 19 '24	Proposed Sale	65.79	112,870	7,425,717		Aug 19 08:00 PM
SINGLETON J MATTHEW	Director	Aug 19 '24	Proposed Sale	62.21	16,000	995,360		Aug 19 07:47 PM
SINGLETON J MATTHEW	Director	Aug 14 '24	Option Exercise	8.00	20,786	166,288	30,286	Aug 14 08:03 PM
SINGLETON J MATTHEW	Director	Aug 14 '24	Sale	57.53	20,786	1,195,736	9,500	Aug 14 08:03 PM
SINGLETON J MATTHEW	Director	Aug 14 '24	Proposed Sale	57.53	20,786	1,195,735		Aug 14 04:38 PM
ZANTE GREG	Chief Financial Officer	Jul 30 '24	Sale	57.15	16,136	922,212	187,052	Jul 31 04:05 PM
Lian Brian	President & CEO	Jul 30 '24	Sale	57.58	115,859	6,670,604	2,354,927	Jul 31 04:05 PM
Mancini Marianna	Chief Operating Officer	Jul 30 '24	Sale	57.13	18,026	1,029,912	362,149	Jul 31 04:05 PM
GREG ZANTE	Officer	Jul 30 '24	Proposed Sale	57.15	16,136	922,232		Jul 30 05:58 PM
MARIANNA MANCINI	Officer	Jul 30 '24	Proposed Sale	57.13	18,026	1,029,888		Jul 30 05:56 PM
BRIAN LIAN	Officer	Jul 30 '24	Proposed Sale	57.58	115,859	6,671,057		Jul 30 05:55 PM
ZANTE GREG	Chief Financial Officer	May 03 '24	Option Exercise	4.86	34,249	166,285	241,610	May 03 08:51 PM
ZANTE GREG	Chief Financial Officer	May 03 '24	Sale	74.69	66,756	4,986,008	174,854	May 03 08:51 PM
Mancini Marianna	Chief Operating Officer	May 01 '24	Option Exercise	6.18	281,425	1,740,575	629,933	May 02 09:27 PM
Mancini Marianna	Chief Operating Officer	May 01 '24	Sale	78.66	281,425	22,136,474	348,508	May 02 09:27 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VKTX

Viking Therapeutics Inc

Upgrade your FINVIZ experience